NFKB1 and non-small cell lung carcinoma: Similar effects of the inhibition of NF-κB on cell cycle arrest at the G2/M phase have been reported in lymphoma [28], [29], Non-Small-Cell Lung Cancer [30] and leukemia cells [31].